International Patient Enquiries |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
Treatment for Liver Cancer
|
Surgery is the treatment of choice for liver cancer. It is therefore crucial that a person with suspected liver cancer is properly assessed by a well-trained liver surgeon. The Hepatobiliary Clinic of the National Cancer Centre Singapore offers co-ordinated management of the disease by a team of experts including highly-trained and experienced hepatopancreaticobiliary (HPB) surgeons.
|
|
What is Liver Surgery or Liver Resection
Liver tumours - either primary liver cancer (hepatocellular carcinoma, HCC) or cancer spreading (metastatic) to the liver as a result of colon cancer - are best treated by surgery.
Liver surgery for the removal of tumours is known as liver resection and involves removing that part of the liver affected by the tumour. The aim of liver resection is to remove all the tumour with a clear margin to obtain primary control and cure for the tumour, and is performed by surgeons specialising in liver surgery - hepatopancreaticobiliary (HPB) surgeons.
 |
Who it is for
The procedure is for patients with primary hepatocellular carcinoma (HCC) and is the only form of treatment that is consistently accepted as curative treatment for this condition. Liver surgery is also possible for metastatic tumours that have spread to the liver from colorectal cancers.
In advanced cancer such as metastatic liver tumours, selected patients benefit from a combination of chemotherapy and surgery. |
Our treatment centre
The HPB Surgery unit of the Department of Surgical Oncology at National Cancer Centre Singapore (NCCS) |
National Cancer Centre Singapore
Proven Expertise
|
| Our HPB team is recognised as a regional leader performing between 80 and 100 HCC cases a year. Trained HPB surgeons, and a high volume of cases helps ensure quality of care and world standard results. |
|
Advanced Methodology
|
| NCCS's reputation for high standards and advanced methods in Liver Resection attracts a regular stream of surgeons from the Asia-Pacific region keen on learning from us. |
|
Positive Outcomes
|
The prognosis of most HCC patients without treatment is a short lifespan of months. Surgery performed by our HPB team have yielded high results of up to 45% 5-year survival, comparable to worldwide standards.
For metastatic liver cancer, although considered as an advanced stage cancer, selected patients benefit from liver resection as well, and in some cases with a combination of chemotherapy and surgery.
Results at NCCS for liver resection for colorectal metastases to the liver show a survival rate of 40-45% at 5 years versus a 7-month median survival with no treatment. |
|
Multidisciplinary Care
|
| The surgical team works with medical and radiation oncologists to derive the optimal course of treatment for the individual patient. When surgery is not possible for HCC, our treatment options include radiofrequency ablation (RFA), and localised chemotherapy known as transarterial chemoembolisation (TACE). |
|
|
Find a Doctor
|
|
Related Videos
|
| |
|
|
Other Surgical Oncology Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Call our 24-hr hotline:
+65 6326 5656 |
|
|
|
|
|
|
|
|
|
|
|
|
|